Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Ambrosi

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Presse Medicale (Paris, France : 1983)|July 6, 2004
[Hyponatremia in elderly patients treated with thiazide diuretics and incited to drink abundantly during the heat wave]Pierre Ambrosi, Patrick Villani, Gilles Bouvenot
Therapie|June 26, 2003
[The statins: new properties]]Pierre Ambrosi, Patrick Villani, Gilbert Habib, et al.
The American Journal of Cardiology|April 15, 2004
Potentials and limitations of color M-Mode and tissue Doppler indexes in identifying pseudonormal mitral filling pattern in patients with acute symptoms of heart failure and preserved left ventricular systolic functionStephane Arques, Pierre Ambrosi, Emmanuel Roux, et al.
La Revue Du Praticien|November 2, 2010
[Therapeutic evaluation and the level of proof]Gilles Bouvenot, Patrick Villani, Julien Bouvenot, et al.
Cardiology|May 11, 2020
Authors' Reply to the Letter by Shoar et al. on "Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo"Pierre Ambrosi, Aurélie Daumas, Patrick Villani, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 27, 2006
Giant left atrial thrombus in a transplanted heartPierre Ambrosi, Olivier Ghez, Alberto Ribéri, et al.
Cardiology|February 24, 2020
Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to PlaceboPierre Ambrosi, Aurélie Daumas, Patrick Villani, et al.
La Revue Du Praticien|January 5, 2011
[Pharmacologic and non-pharmacologic treatments. Legal rules]Gilles Bouvenot, Patrick Villani, Julien Bouvenot, et al.
International Journal of Cardiology|May 19, 2009
Heart transplantation in 7 patients from a single family with limb-girdle muscular dystrophy caused by lamin A/C mutationPierre Ambrosi, Annick Mouly-Bandini, Sharam Attarian, et al.
International Journal of Cardiology|July 30, 2013
Anticoagulation with a new oral anticoagulant in heart transplant recipientsPierre Ambrosi, Bernard Kreitmann, William Cohen, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Presse Medicale (Paris, France : 1983)|July 6, 2004
[Hyponatremia in elderly patients treated with thiazide diuretics and incited to drink abundantly during the heat wave]Pierre Ambrosi, Patrick Villani, Gilles Bouvenot
Therapie|June 26, 2003
[The statins: new properties]]Pierre Ambrosi, Patrick Villani, Gilbert Habib, et al.
The American Journal of Cardiology|April 15, 2004
Potentials and limitations of color M-Mode and tissue Doppler indexes in identifying pseudonormal mitral filling pattern in patients with acute symptoms of heart failure and preserved left ventricular systolic functionStephane Arques, Pierre Ambrosi, Emmanuel Roux, et al.
La Revue Du Praticien|November 2, 2010
[Therapeutic evaluation and the level of proof]Gilles Bouvenot, Patrick Villani, Julien Bouvenot, et al.
Cardiology|May 11, 2020
Authors' Reply to the Letter by Shoar et al. on "Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to Placebo"Pierre Ambrosi, Aurélie Daumas, Patrick Villani, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 27, 2006
Giant left atrial thrombus in a transplanted heartPierre Ambrosi, Olivier Ghez, Alberto Ribéri, et al.
Cardiology|February 24, 2020
Glycosylated Hemoglobin as a Surrogate for the Prevention of Cardiovascular Events in Cardiovascular Outcome Trials Comparing New Antidiabetic Drugs to PlaceboPierre Ambrosi, Aurélie Daumas, Patrick Villani, et al.
La Revue Du Praticien|January 5, 2011
[Pharmacologic and non-pharmacologic treatments. Legal rules]Gilles Bouvenot, Patrick Villani, Julien Bouvenot, et al.
International Journal of Cardiology|May 19, 2009
Heart transplantation in 7 patients from a single family with limb-girdle muscular dystrophy caused by lamin A/C mutationPierre Ambrosi, Annick Mouly-Bandini, Sharam Attarian, et al.
International Journal of Cardiology|July 30, 2013
Anticoagulation with a new oral anticoagulant in heart transplant recipientsPierre Ambrosi, Bernard Kreitmann, William Cohen, et al.
Pageof 8